In the Margins
Hedge-fund billionaire John Paulson has joined the Valeant Pharmaceuticals International board of directors. Paulson has been one of the largest shareholders in the company for several years, but a series of scandals at Valeant over its accounting practices and drug pricing have battered the company’s stock and caused the value of Paulson’s stake to plunge 81% to $245 million at the end of last year from $1.3 billion in 2015. Read the original story from The Wall Street Journal.
Most Read
Mutual fund boards can continue conducting business—including voting on contract approvals and renewals and other important matters—virtually through the end of 2020, according to the Securities ...
Mutual fund boards seem well on their way to mastering the art of conducting business virtually, but one area that may still be a challenge during ...
A majority of independent mutual fund directors did not see a significant increase in compensation last year, particularly if they served on one of the largest ...
The world has been turned upside down in the past two months, and it remains unclear if things will ever go back to what we considered ...